InMode (INMD) Projected to Post Quarterly Earnings on Monday

InMode (NASDAQ:INMD) is expected to be releasing its Q1 2025 earnings data before the market opens on Monday, April 28th. Analysts expect InMode to post earnings of $0.45 per share and revenue of $82.21 million for the quarter.

InMode Stock Up 0.6 %

InMode stock opened at $16.22 on Friday. The company has a market capitalization of $1.13 billion, a P/E ratio of 6.90 and a beta of 1.96. The firm has a 50 day moving average price of $17.36 and a 200-day moving average price of $17.62. InMode has a twelve month low of $13.68 and a twelve month high of $19.85.

Analysts Set New Price Targets

Several brokerages have issued reports on INMD. Needham & Company LLC restated a “hold” rating on shares of InMode in a research note on Wednesday, April 9th. Jefferies Financial Group lowered their price objective on InMode from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Monday, April 14th. Finally, Barclays increased their target price on shares of InMode from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, InMode presently has a consensus rating of “Hold” and an average target price of $21.25.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.